As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
As women’s sports enters what feels like a sustained boom period — the Golden State Valkyries just played their first WNBA next season, the NWSL is expanding, media rights deals are growing — Nortman remains cautiously optimistic about whether this moment will prove different from past surges in interest.
Vibe coding has taken the tech industry by storm, and it’s not just the Lovables and Replits of the world that are winning. The startups building the infrastructure behind them are cashing in too. Supabase, the open-source database platform that’s become the backend of choice for the vibe-coding world, raised $100 million at a $5 billion valuation just months after closing $200 million at $2 billion. But co-founder and CEO […]